litlas
Log inCreate account

Steven A. Rosenberg

Active 1968–2025

Also published as
STEVEN A. ROSENBERG
524
Papers
187,052
Citations
220
h-index
522
i10-index

Citations

Citations per year for Steven A. Rosenberg1968: 1 citations1969: 6 citations1970: 11 citations1971: 9 citations1972: 14 citations1973: 4 citations1974: 13 citations1975: 12 citations1976: 8 citations1977: 4 citations1978: 4 citations1979: 14 citations1980: 17 citations1981: 32 citations1982: 27 citations1983: 42 citations1984: 49 citations1985: 101 citations1986: 171 citations1987: 194 citations1988: 328 citations1989: 239 citations1990: 274 citations1991: 280 citations1992: 267 citations1993: 312 citations1994: 319 citations1995: 385 citations1996: 489 citations1997: 468 citations1998: 579 citations1999: 763 citations2000: 767 citations2001: 741 citations2002: 711 citations2003: 762 citations2004: 853 citations2005: 900 citations2006: 988 citations2007: 1,066 citations2008: 1,226 citations2009: 1,133 citations2010: 1,348 citations2011: 1,294 citations2012: 1,526 citations2013: 1,915 citations2014: 1,589 citations2015: 2,190 citations2016: 2,204 citations2017: 2,452 citations2018: 2,562 citations2019: 5,657 citations2020: 5,895 citations2021: 5,918 citations2022: 4,605 citations2023: 3,730 citations2024: 4,845 citations2025: 2,501 citations2026: 63 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 15,120 citing papers, 36.2% of this breakdownChina: 4,773 citing papers, 11.4% of this breakdownGermany: 2,361 citing papers, 5.6% of this breakdownUnited Kingdom: 2,098 citing papers, 5% of this breakdownItaly: 1,630 citing papers, 3.9% of this breakdownFrance: 1,469 citing papers, 3.5% of this breakdownJapan: 1,207 citing papers, 2.9% of this breakdownNetherlands: 1,169 citing papers, 2.8% of this breakdownCanada: 1,123 citing papers, 2.7% of this breakdownAustralia: 1,067 citing papers, 2.6% of this breakdownSwitzerland: 985 citing papers, 2.4% of this breakdownSpain: 829 citing papers, 2% of this breakdown
0%36.2%Other 19%

Institutions

Fields

  • Medicine54%
  • Immunology and Microbiology24.4%
  • Biochemistry, Genetics and Molecular Biology16.6%
  • Engineering1.6%
  • Neuroscience1.3%
  • Materials Science0.5%
  • Other1.6%

Topics

  • CAR-T cell therapy research11.1%
  • Immunotherapy and Immune Responses10.8%
  • Cancer Immunotherapy and Biomarkers8.4%
  • Immune Cell Function and Interaction7.5%
  • T-cell and B-cell Immunology3.8%
  • Virus-based gene therapy research3.2%
  • Other55.2%

Coauthors

All papers

Open in search
  1. Adoptive cell transfer as personalized immunotherapy for human cancer

    Authors: Steven A. Rosenberg, Nicholas P. Restifo - Science 2015 cited by 2,519

  2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

    Authors: Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, Yongzhi Cui, Cindy Delbrook, Steven A. Feldman, Terry J. Fry, Rimas J. Orentas, Marianna Sabatino, Nirali N. Shah, Seth M. Steinberg, D. Stroncek, Nick Tschernia, Constance M. Yuan, Hua Zhang, Ling Zhang, Steven A. Rosenberg, Alan S. Wayne, Crystal L. Mackall - The Lancet 2014 cited by 2,938

  3. Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

    Authors: Richard A. Morgan, James C. Yang, Mio Kitano, Mark E. Dudley, Carolyn M. Laurençot, Steven A. Rosenberg - Molecular Therapy 2010 cited by 2,538

  4. Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

    Authors: Rom S. Leidner, Nelson Sanjuan Silva, Huayu Huang, David E. Sprott, Chunhong Zheng, Yi-Ping Shih, Amy Leung, Roxanne Payne, Kim Sutcliffe, Julie Cramer, Steven A. Rosenberg, Bernard A. Fox, Walter J. Urba, Eric Tran - New England Journal of Medicine 2022 cited by 509

  5. T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

    Authors: Eric Tran, Paul F. Robbins, Yong‐Chen Lu, Todd D. Prickett, Jared J. Gartner, Lee Jia, Anna Pasetto, Zhili Zheng, Satyajit Ray, Eric Groh, Isaac Kriley, Steven A. Rosenberg - New England Journal of Medicine 2016 cited by 1,355

  6. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer

    Authors: Sri Krishna, Frank J. Lowery, Amy R. Copeland, Erol Bahadiroglu, Ratnadeep Mukherjee, Li Jia, James Anibal, Abraham Sachs, Serifat Adebola, Devikala Gurusamy, Zhiya Yu, Victoria Hill, Jared J. Gartner, Yong F. Li, Maria R. Parkhurst, Biman C. Paria, Pia Kvistborg, Michael C. Kelly, Stephanie L. Goff, Grégoire Altan‐Bonnet, Paul F. Robbins, Steven A. Rosenberg - Science 2020 cited by 556

  7. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers

    Authors: Frank J. Lowery, Sri Krishna, Rami Yossef, Neilesh B. Parikh, Praveen D. Chatani, Nikolaos Zacharakis, Maria R. Parkhurst, Noam Levin, Sivasish Sindiri, Abraham Sachs, Kyle Hitscherich, Zhiya Yu, Nolan R. Vale, Yong‐Chen Lu, Zhili Zheng, Li Jia, Jared J. Gartner, Victoria Hill, Amy R. Copeland, Shirley Nah, Robert V. Masi, Billel Gasmi, Scott Kivitz, Biman C. Paria, Maria Florentin, Sanghyun P. Kim, Ken‐ichi Hanada, Yong F. Li, Lien T. Ngo, Satyajit Ray, Mackenzie L. Shindorf, Shoshana T. Levi, Ryan P. Shepherd, Chris Toy, Anup Y. Parikh, Todd D. Prickett, Michael C. Kelly, Rachel K. Beyer, Stephanie L. Goff, James C. Yang, Paul F. Robbins, Steven A. Rosenberg - Science 2022 cited by 449

  8. Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

    Authors: Vid Leko, Steven A. Rosenberg - Cancer Cell 2020 cited by 422

  9. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

    Authors: Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurençot, Seth M. Steinberg, Donald E. White, Mark E. Dudley - Clinical Cancer Research 2011 cited by 2,120

  10. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

    Authors: Eric Tran, Simon Turcotte, Alena Gros, Paul F. Robbins, Yong‐Chen Lu, Mark E. Dudley, John R. Wunderlich, Robert Somerville, Katherine Hogan, Christian S. Hinrichs, Maria R. Parkhurst, James C. Yang, Steven A. Rosenberg - Science 2014 cited by 1,733

  11. Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

    Authors: Steven A. Rosenberg, Beverly S. Packard, Paul Aebersold, Diane Solomon, Suzanne L. Topalian, Stephen T. Toy, Paul Simon, Michael T. Lotze, James Chih‐Hsin Yang, Claudia A. Seipp, Colleen Simpson, Charles W. Carter, Steven Bock, Douglas J. Schwartzentruber, John P. Wei, Donald E. White - New England Journal of Medicine 1988 cited by 2,345

  12. Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

    Authors: Mojgan Ahmadzadeh, Laura A. Johnson, Bianca Heemskerk, John R. Wunderlich, Mark E. Dudley, Donald E. White, Steven A. Rosenberg - Blood 2009 cited by 1,759

  13. Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    Authors: Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg - Journal of Immunotherapy 2010 cited by 1,238

  14. Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma

    Authors: John Toso, Vee J. Gill, Patrick Hwu, Francesco M. Marincola, Nicholas P. Restifo, Douglas J. Schwartzentruber, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Frida Stock, Linda J. Freezer, Kathleen E. Morton, Claudia A. Seipp, Leah Haworth, Sharon Mavroukakis, Donald White, Susan MacDonald, John Mao, Mario Sznol, Steven A. Rosenberg - Journal of Clinical Oncology 2002 cited by 712

  15. IL-2: The First Effective Immunotherapy for Human Cancer

    Authors: Steven A. Rosenberg - The Journal of Immunology 2014 cited by 1,287

  16. mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

    Authors: Gal Cafri, Jared J. Gartner, Tal Zaks, Kristen Hopson, Noam Levin, Biman C. Paria, Maria R. Parkhurst, Rami Yossef, Frank J. Lowery, Mohammad Jafferji, Todd D. Prickett, Stephanie L. Goff, Christine T. McGowan, Samantha J. Seitter, Mackenzie L. Shindorf, Anup Y. Parikh, Praveen D. Chatani, Paul F. Robbins, Steven A. Rosenberg - Journal of Clinical Investigation 2020 cited by 414

  17. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

    Authors: Alena Gros, Paul F. Robbins, Xin Yao, Yong F. Li, Simon Turcotte, Eric Tran, John R. Wunderlich, Arnold Mixon, Shawn Farid, Mark E. Dudley, Ken‐ichi Hanada, Jorge R. Almeida, Samuel Darko, Daniel C. Douek, James Chih‐Hsin Yang, Steven A. Rosenberg - Journal of Clinical Investigation 2014 cited by 1,108

  18. Adoptive immunotherapy for cancer: harnessing the T cell response

    Authors: Nicholas P. Restifo, Mark E. Dudley, Steven A. Rosenberg - Nature reviews. Immunology 2012 cited by 1,679

  19. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

    Authors: Nikolaos Zacharakis, Harshini Chinnasamy, Mary A. Black, Hui Xu, Yong‐Chen Lu, Zhili Zheng, Anna Pasetto, Michelle M. Langhan, Thomas E. Shelton, Todd D. Prickett, Jared J. Gartner, Lee Jia, Katarzyna Trebska-McGowan, Robert Somerville, Paul F. Robbins, Steven A. Rosenberg, Stephanie L. Goff, Steven A. Feldman - Nature Medicine 2018 cited by 778

  20. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

    Authors: Stephanie L. Goff, Richard A. Morgan, James C. Yang, Richard M. Sherry, Paul F. Robbins, Nicholas P. Restifo, Steven A. Feldman, Yong‐Chen Lu, Lily Lu, Zhili Zheng, Liqiang Xi, Monica Epstein, Lori McIntyre, Parisa Malekzadeh, Mark Raffeld, Howard A. Fine, Steven A. Rosenberg - Journal of Immunotherapy 2019 cited by 376

  21. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

    Authors: Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Gang Wang, Zelig Eshhar, Sharon Mavroukakis, Donald E. White, John R. Wunderlich, Silvana Canevari, Linda Rogers-Freezer, Clara C. Chen, James C. Yang, Steven A. Rosenberg, Patrick Hwu - Clinical Cancer Research 2006 cited by 1,239

  22. T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis

    Authors: Maria R. Parkhurst, James C. Yang, Russell C. Langan, Mark E. Dudley, Debbie-Ann N. Nathan, Steven A. Feldman, Jeremy L. Davis, Richard A. Morgan, Maria J. Merino, Richard M. Sherry, Marybeth S. Hughes, Udai S. Kammula, Giao Q. Phan, Ramona M. Lim, Stephen A. Wank, Nicholas P. Restifo, Paul F. Robbins, Carolyn M. Laurençot, Steven A. Rosenberg - Molecular Therapy 2010 cited by 1,014

  23. Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

    Authors: Kathryn M. Cappell, Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre, Steven A. Rosenberg, James N. Kochenderfer - Journal of Clinical Oncology 2020 cited by 308

  24. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

    Authors: James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler‐Stevenson, Steven A. Feldman, Irina Marić, Mark Raffeld, Debbie-Ann N. Nathan, Brock Lanier, Richard A. Morgan, Steven A. Rosenberg - Blood 2010 cited by 1,335